Paraplegia
Conditions
Keywords
high-intensity interval training, cardiometabolic health
Brief summary
Persons with chronic paraplegia at an increased risk of developing cardiovascular disease and type-2 diabetes compared to the able-bodied population. There is mounting evidence from the able-bodied literature that high-intensity interval training (HIIT) is an effective way to improve cardiometabolic health outcomes, but this effect has yet to be investigated in persons with chronic paraplegia. This study is recruiting adults (aged 18-65 years) with paraplegia (T2 or below) who sustained their spinal cord injury more than one-year ago. Participants will need to attend the laboratory at the University of Bath on two occasions (baseline and follow-up testing) separated by eight weeks. Following the first visit, participants will be randomised to a exercise group or control group. For those in the exercise group, participants will be provided with an arm crank ergometer for use in their home, and be asked to perform four exercise sessions per week (30 min each) for six weeks. For those in the control group, participants will be asked to continue their normal lifestyle.
Detailed description
The aim of this research is to determine the effect of HIIT (vs. a control group) on biomarkers of cardiometabolic health in persons with chronic paraplegia. Baseline and follow-up assessments: Before each visits, participants will be asked to refrain from any strenuous physical activity (2 days prior), consume no caffeine (including tea or coffee) or alcohol (1 day prior), and have fasted for at least 10 hours overnight before arriving to the University of Bath laboratories. There will be measurements of basic anthropometrics (height, weight, waist and hip circumference), body composition (via a DEXA scan), resting metabolic rate, sub-maximal and maximal exercise capacity, and blood responses following the consumption of a sugary drink. Physical activity and diet monitoring: Participants will be asked to monitor their normal diet (weighed food diary) and physical activity patterns (chest-worn strap) over a 1-week period following the first visit, and in the final week of the 6-week intervention/control period. Exercise intervention: The 6-week exercise programme or control will start two weeks after the first lab visit. Participants in the exercise group will be asked to wear a heart-rate monitor for all exercise sessions, and upload their data to a smartphone for remote-monitoring by the research team.
Interventions
BEHAVIORALHigh-intensity interval training
Arm-cranking exercise
Sponsors
University of Bath
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Individuals with a chronic (\>12 months post-injury) SCI below T2 * Individuals who spend \>75% of their waking day in a wheelchair * Weight stable (weight not changed by \>3% over the last 3 months)
Exclusion criteria
* Individuals who an acute (\<12 months post-injury) SCI * Individuals who spend \<75% of their waking day in a wheelchair * Individuals on type-2 diabetes medication * Individuals self-reporting active medical issues (pressure sores, urinary tract infections, cardiac disorders, musculoskeletal complaints of the upper extremities, or cardiovascular contraindications to exercise testing) * Plans to change lifestyle during the study period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fasting insulin | 6 weeks | Serum insulin concentration |
| Peak aerobic capacity | 6 weeks | Measured using a incremental ramp protocol on a arm crank ergometer |
| Peak power output | 6 weeks | Maximum power output achieved during peak aerobic capacity test |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total Fat Mass | 6 weeks | Measured using duel-energy x-ray absorptiometry |
| Total Fat-Free Mass | 6 weeks | Measured using duel-energy x-ray absorptiometry |
| Visceral Adipose Tissue | 6 weeks | Measured using duel-energy x-ray absorptiometry |
| Systolic and diastolic blood pressure | 6 weeks | Measuring using a automated sphygmomanometer |
| Resting metabolic rate | 6 weeks | Measured using indirect calorimetry |
| Time spent in different physical activity intensities (MET categories) (minutes) | 6 weeks | Time spent in different physical activity intensities across 7-days (MET categories) (minutes) |
| Energy expended in different physical activity intensities (MET categories) (kJ or kcal) | 6 weeks | Energy expended in different physical activity intensities across 7-days (MET categories) (kJ or kcal) |
| Body mass | 6 weeks | Measured using electronic wheelchair scales |
| Fasting metabolite/hormone/inflammatory profile | 6 weeks | Assessment of blood glucose, glycated hemoglobin, triglycerides, non-esterified fatty acids, total cholesterol, high density lipoprotein, and low density lipoprotein concentrations, leptin, C-reactive protein, interleukin-6, tumour-necrosis factor-alpha, and adiponectin |
| Postprandial metabolites | 6 weeks | Assessment of blood glucose and insulin |
| Shoulder Pain | 6 weeks | Measured using a validated questionnaire |
| Exercise Self-Efficacy | 6 weeks | Measuring using a validated questionnaire |
| Health-related quality of life | 6 weeks | Measured using a validated questionnaire |
| Fatigue | 6 weeks | Measured using a validated questionnaire |
| Independence | 6 weeks | Measured using a validated questionnaire |
| Energy intake and dietary macronutrient composition | 6 weeks | Estimated using a 7-day weighed food diary |
| Waist and hip circumference | 6 weeks | Measured using a non-metallic tape |
| Total body fat percentage | 6 weeks | Measured using duel-energy x-ray absorptiometry |
Countries
United Kingdom
Contacts
Primary ContactJames Bilzon
Outcome results
None listed